Biomarkers
578 results
| Analyte | Technology | Species | Matrix* | Status | Range | LOD | CV |
|---|---|---|---|---|---|---|---|
| angiopoietin like 4 | TECAN | Human | CP/S | Experienced | 20 - 20 000 pg/ml | ||
| endothelin 2 | TECAN | Human | CP/S | Experienced | 10 - 1000 pg/ml | ||
| LOX-1/OLR1 | TECAN | Human | CP/S | Experienced | 2 - 500 pg/ml | ||
| SPINK1 | TECAN | Human | CP/S | Experienced | 1,23 - 300 pg/ml | ||
| IL-17 | TECAN | Human | CP/S | Experienced | 0,5 - 100 pg/ml | ||
| GM-CSF | TECAN | Human | CP/S | Experienced | 3 - 500 pg/ml | ||
| VWF Rco | STA-R MAX | Human | Qualified | ||||
| β-CrossLaps/serum | Cobas e 801 | Human | Qualified | ||||
| VEGF-C | Simoa | Human | CP/S | Not available | |||
| VEGF-D | Simoa | Human | E/S | 0 - 40 000 | 5,82 | ||
| VEGF-R1 | Simoa | Human | E/S | 0 - 27 500 | 0,573 | ||
| VEGF-R2 | Simoa | Human | E/S | 0 - 35 000 | 0,821 | ||
| VEGF-R3 | Simoa | Human | E/S | 0 - 10 ug/ml | 48,3 | ||
| Vitamin B12 II | Cobas e 801 | Human | Qualified | ||||
| Vitamin D25 OH | cobas c 503 | Human | Qualified | ||||
| VWF activity | ACL TOP 700 | Human | CP | Experienced | 19 - 130% | ||
| VWF Ag | STA-R MAX | Human | Qualified | ||||
| VWF Ag quantitative determination | ACL TOP 700 | Human | CP | Experienced | 8,5 - 250% | ||
| UCH-L1 | Simoa | Human | CSF/E/S | 0-40 000 pg/ml | 2,43 pg/ml | ||
| Urea | cobas c 503 | Human | S/U | Qualified | |||
| Uric acid | cobas c 503 | Human | S/U | Qualified | |||
| VCAM-1 | Bio-Plex® 200 system | Human | CP/S | ||||
| VCAM-1 | Bio-Plex® 200 system | Human | |||||
| VEGF | Simoa | Human | E/S | 0 - 15 200 | 0,88 | ||
| VEGF | Bio-Plex® 200 system | Human | CP/S | ||||
| VEGF | Simoa | Human | 0-3900 | 1,6 | |||
| VEGF | Simoa | Human | CP/S | Not available | |||
| VEGF-C | Simoa | Human | E/S | 0- 64 000 | 5,67 | ||
| TPA | TECAN | Human | CP | Experienced | 1,5 - 65 ng/ml | ||
| Transferrin | cobas c 503 | Human | Qualified | ||||
| TRH test | cobas c 503 | Human | Qualified | ||||
| Triglycerides | cobas c 503 | Human | Qualified | ||||
| Troponin I | Cobas e 801 | Human | Qualified | ||||
| Troponin T hs | Cobas e 801 | Human | Qualified | ||||
| TSH | Cobas e 801 | Human | Qualified | ||||
| TSI | cobas c 503 | Human | Qualified | ||||
| TSP-2 | Simoa | Human | E/S | 0 - 3 000 ng/ml | 12,6 | ||
| UCH-L1 | Simoa | Human | CSF/E/S | 0-40 000 pg/ml | 1,74 pg/ml | ||
| TNF-α | Simoa | NHP | 0,47 | ||||
| Total bicarbonate CO2 | cobas c 503 | Human | Qualified | ||||
| Total cholesterol | cobas c 503 | Human | Qualified | ||||
| total P1NP | Cobas e 801 | Human | Qualified | ||||
| Total protein | cobas c 503 | Human | S/U | Qualified | |||
| Total testosteron | cobas c 503 | Human | Qualified | ||||
| Total-Tau CSF | Cobas e 801 | Human | Qualified | ||||
| Toxo IgG | Cobas e 801 | Human | Qualified | ||||
| Toxo IgG Avidity | Cobas e 801 | Human | Qualified | ||||
| Toxo IgM | Cobas e 801 | Human | Qualified | ||||
| TIMP-2 | Simoa | Human | E/S | 0 - 10 000 ng/ml | 4,63 | ||
| TNF-RI | Simoa | Human | E/S | 0 - 60 000 | 0,208 | ||
| TNF-α | Simoa | Human | E/S | 0-400 pg/ml | 0,016 pg/ml | ||
| TNF-α | Simoa | Human | E/S | 0-1600 pg/ml | 0,055 pg/ml | ||
| TNF-α | Simoa | Human | E/S | 0-1600 | 0,055 | ||
| TNF-α | Bio-Plex® 200 system | Human | CP/S | ||||
| TNF-α | Bio-Plex® 200 system | Human | CP/S | ||||
| TNF-α | Bio-Plex® 200 system | Human | CP/S | ||||
| TNF-α | Bio-Plex® 200 system | Human | CP/S | ||||
| TNF-α | Simoa | Rat | 0 - 51 200 | 1,67 | |||
| Thrombine time | ST Genesia | Human | CP | Qualified | |||
| Thyroglobuline | cobas c 503 | Human | Qualified | ||||
| TIE-2 | Simoa | Human | E/S | 0 - 200 | 6,90 | ||
| TIMP-1 | Simoa | Human | E/S | 0-5000 | 0,22 | ||
| Thrombin time | STA-R MAX | Qualified | |||||
| Thrombin time | Start Max | Qualified | |||||
| Thrombine time | ACL TOP 700 | Human | CP | Qualified | |||
| Thrombine time | STA-R MAX | Human | CP | ||||
| Thrombin generation assay | CAT | Human | CP | Qualified | |||
| TIMP-1 | Simoa | Human | E/S | Not available | |||
| TGT | ST Genesia | Human | CP | Qualified | |||
| TGF-β | Simoa | Human | E/S | 0 - 24 ng/ml | 0,137 | ||
| TGF-β1 | Simoa | Human | E/S | Not available | |||
| TGF-β2 | Simoa | Human | E/S | 0 - 54 000 | 6,19 | ||
| TGFb | Simoa | Human | E/S | 0-24 ng/ml | 0,137 pg/ml | ||
| TGT | CAT | Human | CP | Experienced | |||
| Testosterone II | Cobas e 801 | Human | Qualified | ||||
| Tg II | Cobas e 801 | Human | Qualified | ||||
| Tg II confirmatory test | Cobas e 801 | Human | Qualified | ||||
| TGF-α | Simoa | Human | E/S | 0 - 2 880 | 0,262 | ||
| TDP-43 | Simoa | Human | CSF/E/S | 0-8000 pg/ml | 2,48 pg/ml | ||
| TECK / CCL25 | Bio-Plex® 200 system | Human | CP/S | ||||
| Tau | Simoa | Human | CSF/E/S | 0-360 pg/ml | 0,019 pg/ml | ||
| Tau | Simoa | Human | CSF/E | 0-400 pg/ml | 0,019 | ||
| Tau | Simoa | Human | CSF/E/S | 0-400 pg/ml | 0,024 pg/ml | ||
| Tau | Simoa | Human | CSF/E/S | 0-400 pg/ml | 0,037 pg/ml | ||
| Tacrolimus | Cobas e 801 | Human | Qualified | ||||
| Tacrolimus | cobas c 503 | Human | Qualified | ||||
| TAFI | STA-R MAX | Qualified | |||||
| TARC / CCL17 | Bio-Plex® 200 system | Human | CP/S | ||||
| T-Uptake | Cobas e 801 | Human | Qualified | ||||
| t3 | Cobas e 801 | Human | Qualified | ||||
| t4 | Cobas e 801 | Human | Qualified | ||||
| SNAP-25 | Simoa | Human | CSF | 0-1000 pg/ml | 0,880 pg/ml | ||
| Sodium | cobas c 503 | Human | S/U | Qualified | |||
| sTNFRII | Simoa | Human | E/S | Not available | |||
| Seric Lithium | cobas c 503 | Human | Qualified | ||||
| sFlt-1 | Cobas e 801 | Human | Qualified | ||||
| SHBG | Cobas e 801 | Human | Qualified | ||||
| Sirolimus | Cobas e 801 | Human | Qualified | ||||
| SDF-1α+β / CXCL12 | Simoa | Human | E/S | 0 - 19 200 | 8,28 | ||
| Seric folic acid | cobas c 503 | Human | Qualified | ||||
| sCD40L | Bio-Plex® 200 system | Human | CP/S | ||||
| SCYB16 / CXCL16 | Bio-Plex® 200 system | Human | CP/S | ||||
| SDF-1α+β / CXCL12 | Bio-Plex® 200 system | Human | CP/S | ||||
| SARS-Cov-2 N Protein Antigen | Simoa | Human | E/S | Experienced | 0-800 pg/ml | 0,099 pg/ml | |
| SARS-CoV-2 Spike IgG | Simoa | Human | E/S | Experienced | 0-280 ug/ml | 15,0 pg/ml | |
| SCC | Cobas e 801 | Human | Qualified | ||||
| S100 | Cobas e 801 | Human | Qualified | ||||
| SAA | Simoa | Human | E/S | 0 - 400 ug/ml | 65,40 | ||
| Rubella IgM | Cobas e 801 | Human | Qualified | ||||
| Reptilase time | Start Max | Qualified | |||||
| Rhumatoid factor | cobas c 503 | Human | Qualified | ||||
| Rivaroxaban | UHPLC-MS/MS | Experienced | |||||
| Rubella IgG | Cobas e 801 | Human | Qualified | ||||
| RANTES / CCL5 | Bio-Plex® 200 system | Human | CP/S | ||||
| RANTES / CCL5 | Bio-Plex® 200 system | Human | CP/S | ||||
| RANTES / CCL5 | Simoa | Human | E/S | Not available | |||
| Reptilase time | STA-R MAX | Qualified | |||||
| RANTES / CCL5 | Simoa | Human | E/S | 0-800 | 0,09 | ||
| RAGE | Simoa | Human | E/S | 0 - 15 000 | 0,302 | ||
| RANKL | Simoa | Human | E/S | 0 - 1 300 | 55,0 fg/ml | ||
| PTH (1-84) | Cobas e 801 | Human | Qualified | ||||
| Quantitative determination of Sex hormone-binding globulin (SHBG) | Cobas e 801 | Human | S | Qualified | |||
| pTau 181 V2.1 | Simoa | Human | CSF/E/S | 0-1280 pg/ml | 0,62 pg/ml | ||
| pTau 231 | Simoa | Human | CSF | 0-1200 pg/ml | 0,621 pg/ml | ||
| PTH | Cobas e 801 | Human | Qualified | ||||
| PSA | cobas c 503 | Human | Qualified | ||||
| PT (quick and Owren PT) | STA-R MAX | Qualified | |||||
| PT (quick and Owren PT) | Start Max | Qualified | |||||
| PSA | Simoa | Human | E/S | 0-400 pg/ml | 0,015 pg/ml | ||
| Prothrombine Fragment 1+2 | TECAN | Human | CP | Validated | 20 - 1200 pM | 7,4% | |
| Prothrombine time | ACL TOP 700 | Human | CP | Qualified | |||
| Prothrombine time | STA-R MAX | Human | CP | ||||
| Protein C | Start Max | Qualified | |||||
| Protein S | STA-R MAX | Qualified | |||||
| Protein S | Start Max | Qualified | |||||
| Prolactin II | Cobas e 801 | Human | Qualified | ||||
| Protein C | ACL TOP 700 | Human | CP | ISO/IEC 17025 certified | 10 - 150% | 4,8% | |
| Protein C | STA-R MAX | Qualified | |||||
| ProGRP | Cobas e 801 | Human | Qualified | ||||
| PMN Elastase | TECAN | Human | E | Experienced | 0,1 - 40,7 | ||
| Potassium | cobas c 503 | Human | S/U | Qualified | |||
| Prealbumin | cobas c 503 | Human | Qualified | ||||
| Procalcitonin | cobas c 503 | Human | Qualified | ||||
| Progesterone III | Cobas e 801 | Human | Qualified | ||||
| PIGF | Cobas e 801 | Human | Qualified | ||||
| Plasminogen | STA-R MAX | Qualified | |||||
| PLGF | Simoa | Human | E/S | 0 - 2000 | 0,13 | ||
| PlGF | Simoa | Human | E/S | Not available | |||
| Phosphorus | cobas c 503 | Human | S/U | Qualified | |||
| PIGF | Simoa | Human | E/S | 0-960 pg/ml | 0,064 pg/ml | ||
| PIGF | Simoa | Human | 0-500 | 0,2 | |||
| Phenobabital | cobas c 503 | Human | Qualified | ||||
| Phenytoin | cobas c 503 | Human | Qualified | ||||
| Phospho-Tau (181P) CSF | Cobas e 801 | Human | Qualified | ||||
| PDGF-AB | Simoa | Human | E/S | 0 - 24 000 | 4,74 | ||
| PDGF-BB | Simoa | Human | E/S | 0 - 4 800 | 0,46 | ||
| PDGF-BB | Bio-Plex® 200 system | Human | CP/S | ||||
| PDGF-BB | Simoa | Human | E/S | Not available | |||
| NSE | Simoa | Human | E/S | Not available | |||
| NSE | Cobas e 801 | Human | Qualified | ||||
| NT proBNP | cobas c 503 | Human | Qualified | ||||
| PD-L1 | Simoa | Human | E/S | 0-4,3 ng/ml | 0,055 pg/ml | ||
| PD-L1 | Simoa | Human | E/S | 0 - 100 ng/ml | 3,11 | ||
| PDGF-AA | Simoa | Human | E/S | 0 - 25 000 | 67,6 fg/ml | ||
| Oestradiol online | cobas c 503 | Human | Qualified | ||||
| OPN | Simoa | Human | E/S | 0 -750 ng/ml | 17,8 | ||
| PAPP-A | Cobas e 801 | Human | Qualified | ||||
| Paracetamol | cobas c 503 | Human | Qualified | ||||
| Mutations Factor V Leiden and Prothrombin G20210A | Light Cycler 480 II (Roche) | Human | WB | Qualitative | N/A | ||
| Myoglobin | Cobas e 801 | Human | Qualified | ||||
| N-MID Osteocalcin | Cobas e 801 | Human | Qualified | ||||
| nAPCsr | CAT | Human | CP | ISO/IEC 17025 certified | |||
| nAPCsr | ST Genesia | Human | CP | Qualified | |||
| NF-light | Simoa | Human | CSF/E/S | 0-2000 pg/ml | 0,065 pg/ml | ||
| NF-light | Simoa | Human | CSF/E/S | 0-2000 pg/ml | 0,104 pg/ml | ||
| NF-light | Simoa | Human | CSF/E/S | 0-2000 pg/ml | 0,096 pg/ml | ||
| NF-light | Simoa | Human | CSF/E/S | 0-2000 pq/ml | 0,090 | ||
| NF-light V2 | Simoa | Human | CSF/E/S | Experienced | 0-1440 pg/ml | 0,085 pg/ml | |
| MIP-3α / CCL20 | Simoa | Human | CP/S | Not available | |||
| MIP-3β | Simoa | Human | E/S | 0-400 | 0,01 | ||
| MIP-3β / CCL19 | Simoa | Human | E/S | 0 - 4000 | 0,065 | ||
| MIP-3β / CCL19 | Bio-Plex® 200 system | Human | CP/S | ||||
| MIP-3β / CCL19 | Simoa | Human | E/S | Not available | |||
| MIP-4 (PARC) | Simoa | Human | CSF/E | 0 - 1 000 | 70,3 fg/ml | ||
| MMP-2 | Simoa | Human | E/S | 0 - 12 800 ng/ml | 68 | ||
| MMP-3 | Simoa | Human | E/S | Not available | |||
| MPIF-1 / CCL23 | Bio-Plex® 200 system | Human | CP/S | ||||
| MPO | TECAN | Human | E | Experienced | 156 - 10 000 pg/mL | ||
| MIP-1α | Simoa | Rat | 0,088 | ||||
| MIP-1α / CCL3 | Bio-Plex® 200 system | Human | CP/S | ||||
| MIP-1α / CCL3 | Bio-Plex® 200 system | Human | CP/S | ||||
| MIP-1α / CCL3 | Bio-Plex® 200 system | Human | CP/S | ||||
| MIP-1β | Bio-Plex® 200 system | Human | CP/S | ||||
| MIP-1β | Bio-Plex® 200 system | Human | CP/S | ||||
| MIP-1δ / CCL15 | Bio-Plex® 200 system | Human | CP/S | ||||
| MIP-2 | Simoa | Rat | 0,23 | ||||
| MIP-3α | Simoa | Rat | 1,8 | ||||
| MIP-3α / CCL20 | Bio-Plex® 200 system | Human | CP/S | ||||
| MCP-3 / CCL7 | Simoa | Human | E/S | Not available | |||
| MCP-4 / CCL13 | Bio-Plex® 200 system | Human | E/S | ||||
| MDC / CCL22 | Simoa | Human | E/S | 0 - 8 000 | 25,6 fg/ml | ||
| MDC/CCL22 | Bio-Plex® 200 system | Human | E/S | ||||
| Methadon | cobas c 503 | Human | U | Qualified | |||
| Microparticles | STA-R MAX | Qualified | |||||
| MIF | Bio-Plex® 200 system | Human | CP/S | ||||
| MIG | Bio-Plex® 200 system | Human | CP/S | ||||
| MIG / CXCL9 | Bio-Plex® 200 system | Human | CP/S | ||||
| MIG / CXCL9 | Simoa | Human | E/S | 0 - 1 600 | 89,0 fg/ml | ||
| MB Fraction | cobas c 503 | Human | Qualified | ||||
| MCP-1 | Simoa | Human | E/S | 0-600 | 0,56 | ||
| MCP-1 | Simoa | Rat | 0,21 | ||||
| MCP-1 (MCAF) / CCL2 | Simoa | Human | E/S | 0 - 6000 | 0,511 | ||
| MCP-1 (MCAF) / CCL2 | Bio-Plex® 200 system | Human | E/S | ||||
| MCP-1 (MCAF) / CCL2 | Bio-Plex® 200 system | Human | CP/S | ||||
| MCP-1 (MCAF) / CCL2 | Bio-Plex® 200 system | Human | CP/S | ||||
| MCP-1 (MCAF) / CCL2 | Simoa | Human | E/S | 0 - 6 000 | 0,511 | ||
| MCP-2/CCL8 | Bio-Plex® 200 system | Human | E/S | ||||
| MCP-3 / CCL7 | Bio-Plex® 200 system | Human | E/S | ||||
| LDH | cobas c 503 | Human | Qualified | ||||
| LH | Cobas e 801 | Human | Qualified | ||||
| LH online | cobas c 503 | Human | Qualified | ||||
| LIF | Simoa | Human | CP/S | Not available | |||
| Lipase | cobas c 503 | Human | Qualified | ||||
| Lipoprotein | cobas c 503 | Human | Qualified | ||||
| Lupus Anticoagulants | STA-R MAX | Qualified | |||||
| Lupus Anticoagulants | Start Max | Qualified | |||||
| M-CSF | Simoa | Human | E/S | 0 - 16 000 | 0,896 | ||
| Magnesium | cobas c 503 | Human | S/U | Qualified | |||
| IP-10/CXCL10 | Bio-Plex® 200 system | Human | CP/S | ||||
| IP-10/CXCL10 | Bio-Plex® 200 system | Human | CP/S | ||||
| IP-10/CXCL10 | Bio-Plex® 200 system | Human | E/S | ||||
| Iron | cobas c 503 | Human | Qualified | ||||
| Ischemia test | cobas c 503 | Human | Qualified | ||||
| ITAC | Simoa | Human | E/S | 0-100 | 0,02 | ||
| KC | Simoa | Rat | 0 - 1 600 | 0,20 | |||
| KGF | Simoa | Human | E/S | 0 - 2 000 | 0,00287 | ||
| Lactic acid (LCR) | cobas c 503 | Human | Qualified | ||||
| Lactic acid (liquid) | cobas c 503 | Human | Qualified | ||||
| IP-10 / CXCL10 | Simoa | Human | CP/S | Not available | |||
| IP-10 / CXCL10 | Simoa | Human | E/S | 0 - 3 000 | 0,146 | ||
| IP-10 | Simoa | Human | E/S | 0-300 | 0,19 | ||
| IP-10 | Simoa | Human | E/S | 0-800 pg/ml | 0,052 pg/ml | ||
| Intrinsic pathway factors | Start Max | Qualified | |||||
| Intrinsic pathway factors | STA-R MAX | Qualified | |||||
| Interferon Gamma | Cobas e 801 | Human | Qualified | ||||
| Insulin | cobas c 503 | Human | Qualified | ||||
| Insulin | Cobas e 801 | Human | Qualified | ||||
| IL12p70 | Simoa | Human | E/S | 0-2400 | 0,044 | ||
| IL-9 | Bio-Plex® 200 system | Human | CP/S | ||||
| IL-8/CXCL8 | Simoa | Human | CP/S | Not available | |||
| IL-8/CXCL8 | Simoa | Human | CP/S | Not available | |||
| IL-8/CXCL8 | Bio-Plex® 200 system | Human | CP/S | ||||
| IL-8/CXCL8 | Bio-Plex® 200 system | Human | E/S | ||||
| IL-8 | Simoa | NHP | 0,012 | ||||
| IL-8 | Bio-Plex® 200 system | Human | CP/S | ||||
| IL-8 | Simoa | Human | E/S | 0-1600 | 0,364 | ||
| IL-8 | Simoa | Human | E/S | 0-1600 pg/ml | 0,0364 pg/ml | ||
| IL-7 | Bio-Plex® 200 system | Human | CP/S | ||||
| IL-7 | Bio-Plex® 200 system | Human | CP/S | ||||
| IL-7 | Simoa | Human | E/H/S | 0-600 pg/ml | 0,009 pg/ml | ||
| IL-6R | Simoa | Human | E/S | 0 - 1 600 ng/ml | 0,0771 | ||
| IL-6 | Cobas e 801 | Human | Qualified | ||||
| IL-6 | Bio-Plex® 200 system | Human | CP/S | ||||
| IL-6 | Simoa | NHP | 0,005 | ||||
| IL-6 | Simoa | Rat | 0 - 8 530 | 1,52 | |||
| IL-6 | Bio-Plex® 200 system | Human | CP/S | ||||
| IL-6 | Bio-Plex® 200 system | Human | CP/S | ||||
| IL-6 | Simoa | Human | E/S | 0 - 250 | 0,010 | ||
| IL-6 | Bio-Plex® 200 system | Human | E/S | ||||
| IL-6 | Simoa | Human | E/S | 0-456 | 0,038 | ||
| IL-6 | Simoa | Human | E/S | 0-456 pg/ml | 0,038 pg/ml | ||
| IL-6 | Simoa | Human | E/S | 0-120 pg/ml | 0,0055 pg/ml | ||
| IL-5 | Bio-Plex® 200 system | Human | CP/S | ||||
| IL-5 | Bio-Plex® 200 system | Human | CP/S | ||||
| IL-5 | Simoa | Human | E/S | 0-800 | 0,012 | ||
| IL-5 | Simoa | Human | E/S | 0-800 pg/ml | 0,012 pg/ml | ||
| IL-5 | Simoa | Human | E/S | 0-12 pg/ml | 0,004 pg/ml | ||
| IL-4 | Bio-Plex® 200 system | Human | CP/S | ||||
| IL-4 | Bio-Plex® 200 system | Human | CP/S | ||||
| IL-4 | Bio-Plex® 200 system | Human | CP/S | ||||
| IL-4 | Bio-Plex® 200 system | Human | E/S | ||||
| IL-4 | Simoa | Human | E/S | 0-400 | 0,014 | ||
| IL-4 | Simoa | Human | E/S | 0-400 pg/ml | 0,1014pg/ml | ||
| IL-4 | Simoa | Human | E/S | 0-200 pg/ml | 0,0046 pg/ml | ||
| IL-33 | Bio-Plex® 200 system | Human | CP/S | ||||
| IL-31 | Bio-Plex® 200 system | Human | CP/S | ||||
| IL-3 | Simoa | Human | E/S | 0 - 6 400 | 0,605 | ||
| IL-2RG | Simoa | Human | E/S | 0 - 12 000 | 1,69 | ||
| IL-25 | Bio-Plex® 200 system | Human | CP/S | ||||
| IL-23 | Bio-Plex® 200 system | Human | CP/S | ||||
| IL-22 | Bio-Plex® 200 system | Human | CP/S | ||||
| IL-22 | Simoa | Human | E/S | 0-400 | 0,01 | ||
| IL-22 | Simoa | Human | E/S | 0-400 pg/ml | 0,01 pg/ml | ||
| IL-21 | Bio-Plex® 200 system | Human | CP/S | ||||
| IL-21 | Simoa | Human | CP/S | Not available | |||
| IL-2 | Bio-Plex® 200 system | Human | CP/S | ||||
| IL-2 | Simoa | Rat | 0 - 6 400 | 0,91 | |||
| IL-2 | Bio-Plex® 200 system | Human | CP/S | ||||
| IL-2 | Bio-Plex® 200 system | Human | E/S | ||||
| IL-2 | Simoa | Human | E/S | 0-120 pg/ml | 0,000893 pg/ml | ||
| IL-1β | Bio-Plex® 200 system | Human | CP/S | ||||
| IL-1β | Simoa | NHP | 0,09 | ||||
| IL-1β | Simoa | Rat | 0 - 12 800 | 0,66 | |||
| IL-1β | Bio-Plex® 200 system | Human | CP/S | ||||
| IL-1β | Simoa | Human | E/S | 0 - 100 | 0,004 | ||
| IL-1β | Bio-Plex® 200 system | Human | E/S | ||||
| IL-1β | Simoa | Human | E/S | 0-800 | 0,024 | ||
| IL-1β | Simoa | Human | E/S | 0-800 pg/ml | 0,024pg/ml | ||
| IL-1α | Simoa | Human | E/S | 0 - 3 600 | 0,0617 | ||
| IL-1RA | Simoa | Human | E/S | 0 - 16 000 | 4,04 | ||
| IL-1ra | Bio-Plex® 200 system | Human | CP/S | ||||
| IL-1b | Simoa | Human | E/S | 0-240 pg/ml | 0,016 pg/ml | ||
| IL-18 | Simoa | Human | E/S | 0 - 3 000 | 37,2 fg/ml | ||
| IL-18 | Bio-Plex® 200 system | Human | CP/S | ||||
| IL-17C | Simoa | Human | E/S | Not available | |||
| IL-17A | Simoa | Human | E/S | Experienced | 0-120 pg/ml | 0,0042 pg/ml | |
| IL-17 | Bio-Plex® 200 system | Human | CP/S | ||||
| IL-17 | Bio-Plex® 200 system | Human | CP/S | ||||
| IL-17 | Bio-Plex® 200 system | Human | CP/S | ||||
| IL-16 | Bio-Plex® 200 system | Human | E/S | ||||
| IL-15 | Simoa | Human | E/S | 0 - 1 600 | 0,256 | ||
| IL-15 | Bio-Plex® 200 system | Human | CP/S | ||||
| IL-15 | Bio-Plex® 200 system | Human | CP/S | ||||
| IL-15 | Simoa | Human | E/S | 0-40 pg/ml | 0,003 pg/ml | ||
| IL-13 | Bio-Plex® 200 system | Human | CP/S | ||||
| IL-13 | Simoa | Human | E/S | 0 - 800 | 0,00876 | ||
| IL-13 | Bio-Plex® 200 system | Human | CP/S | ||||
| IL-12p70 | Simoa | Human | CP/S | Not available | |||
| IL-12p70 | Bio-Plex® 200 system | Human | CP/S | ||||
| IL-12p70 | Simoa | Human | E/S | 0-2400 pg/ml | 0,044 pg/ml | ||
| IL-12p70 | Simoa | Human | E/S | 0-40 pg/ml | 0,0048 pg/ml | ||
| IL-10 | Bio-Plex® 200 system | Human | CP/S | ||||
| IL-10 | Bio-Plex® 200 system | Human | CP/S | ||||
| IL-10 | Simoa | Rat | 0 - 6 400 | 0,36 | |||
| IL-10 | Simoa | Human | CP/S | Not available | |||
| IL-10 | Bio-Plex® 200 system | Human | CP/S | ||||
| IL-10 | Simoa | Human | E/S | 0 - 250 | 0,016 | ||
| IL-10 | Bio-Plex® 200 system | Human | E/S | ||||
| IL-10 | Simoa | Human | E/S | 0-800 | 0,032 | ||
| IL-10 | Simoa | Human | E/S | 0-800 pg/ml | 0,032 pg/ml | ||
| IL-10 | Simoa | Human | E/S | 0-120 pg/ml | 0,0038 pg/ml | ||
| IGRA SARS-CoV-2 | Cobas e 801 | Human | Qualified | ||||
| IgM VCA | Cobas e 801 | Human | Qualified | ||||
| IgM toxo | Cobas e 801 | Human | Qualified | ||||
| IgM total | Bio-Plex® 200 system | Human | CP/S | ||||
| IgM Rubeole | Cobas e 801 | Human | Qualified | ||||
| IgM pediatric | Cobas e 801 | Human | Qualified | ||||
| IgM | Cobas e 801 | Human | Qualified | ||||
| IgM | Bio-Plex® 200 system | Human | CP/S | ||||
| IgG4 | Bio-Plex® 200 system | Human | CP/S | ||||
| IgG3 | Bio-Plex® 200 system | Human | CP/S | ||||
| IgG2 | Bio-Plex® 200 system | Human | CP/S | ||||
| IgG1 | Bio-Plex® 200 system | Human | CP/S | ||||
| IgG VCA | Cobas e 801 | Human | Qualified | ||||
| IgG Toxo | Cobas e 801 | Human | Qualified | ||||
| IgG total | Bio-Plex® 200 system | Human | CP/S | ||||
| IgG Rubeole | Cobas e 801 | Human | Qualified | ||||
| IgG online | Cobas e 801 | Human | Qualified | ||||
| IgE total | Bio-Plex® 200 system | Human | CP/S | ||||
| IgE II | Cobas e 801 | Human | Qualified | ||||
| IgE | Simoa | Human | E/S | 0 - 5 600 | 0,216 | ||
| IgA total | Bio-Plex® 200 system | Human | CP/S | ||||
| IgA pediatric | Cobas e 801 | Human | Qualified | ||||
| IgA | Cobas e 801 | Human | Qualified | ||||
| IgA | Bio-Plex® 200 system | Human | CP/S | ||||
| IFNa | Simoa | Human | S | 0-60 pg/ml | 0,003 pg/ml | ||
| IFN-ɣ | Bio-Plex® 200 system | Human | CP/S | ||||
| IFN-ɣ | Bio-Plex® 200 system | Human | CP/S | ||||
| IFN-ɣ | Simoa | NHP | 0,36 | ||||
| IFN-ɣ | Simoa | Rat | 0 - 51 200 | 10,48 | |||
| IFN-ɣ | Bio-Plex® 200 system | Human | CP/S | ||||
| IFN-ɣ | Bio-Plex® 200 system | Human | E/S | ||||
| IFN-ɣ | Simoa | Human | E/S | 0-200 | 0,011 | ||
| IFN-ɣ | Simoa | Human | E/S | 0-200 pg/ml | 0,011 pg/ml | ||
| IFN-ɣ | Simoa | Human | E/H/S | 0-400 pg/ml | 0,015 pg/ml | ||
| ICAM-1 | Bio-Plex® 200 system | Human | |||||
| ICAM-1 | Bio-Plex® 200 system | Human | CP/S | ||||
| I-TAC / CXCL11 | Simoa | Human | CP/S | Not available | |||
| I-TAC / CXCL11 | Bio-Plex® 200 system | Human | E/S | ||||
| I-TAC / CXCL11 | Simoa | Human | E/S | 0 - 1 000 | 0,031 | ||
| I-309/CCL1 | Simoa | Human | E/S | 0 - 1 600 | 0,644 | ||
| I-309/CCL1 | Bio-Plex® 200 system | Human | E/S | ||||
| HTLV-I/II | Cobas e 801 | Human | Qualified | ||||
| HSV-2 IgG | Cobas e 801 | Human | Qualified | ||||
| Homocystein | cobas c 503 | Human | Qualified | ||||
| HIV p24 | Simoa | Human | E/S | NA | 0,0027 pg/ml | ||
| HIV Ag | Cobas e 801 | Human | Qualified | ||||
| HIV Ac | Cobas e 801 | Human | Qualified | ||||
| hGH | Cobas e 801 | Human | Qualified | ||||
| HGH | Simoa | Human | S | 0-10 ng/ml | 0,545 | ||
| HGF | Simoa | Human | 0-6300 | 1 | |||
| HGF | Simoa | Human | E/S | 0 - 25 600 | 0,74 | ||
| Hepatite C | cobas c 503 | Human | Qualified | ||||
| HE4 | Cobas e 801 | Human | Qualified | ||||
| HE4 | Simoa | Human | CP/S | Not available | |||
| HCV Duo | Cobas e 801 | Human | Qualified | ||||
| HCG+β | Cobas e 801 | Human | Qualified | ||||
| HCG STAT | Cobas e 801 | Human | Qualified | ||||
| HBsAg II quant II | Cobas e 801 | Human | Qualified | ||||
| HBEGF | Simoa | Human | 0-125 | 0,014 | |||
| HBeAg | Cobas e 801 | Human | Qualified | ||||
| HB-EGF | Simoa | Human | CP/S | Not available | |||
| HB-EGF | Simoa | Human | E/S | 0 - 500 | 0,046 | ||
| Haptoglobin | cobas c 503 | Human | Qualified | ||||
| H3R8 Cit Histone | TECAN | Human | E | Experienced | 0,0 - 200 ng mL | ||
| H3.1 Histone | TECAN | Human | E | Experienced | 22,7 - 650 ng/mL | 9,1 ng/ML | |
| Gro-β / CXCL2 | Bio-Plex® 200 system | Human | E/S | ||||
| Gro-α / CXCL1 | Bio-Plex® 200 system | Human | E/S | ||||
| Granzyme B | Simoa | Human | CP/S | 0-10 ng/ml | 0,547 | ||
| GP130 | Simoa | Human | CP/S | 0 - 7 200 ng/ml | 0,754 | ||
| GM-CSF | Bio-Plex® 200 system | Human | CP/S | ||||
| GM-CSF | Bio-Plex® 200 system | Human | E/S | ||||
| GM-CSF | Simoa | Human | E/S | Experienced | 0-120 pg/ml | 0,0019pg/ml | |
| Glycemia | cobas c 503 | Human | Qualified | ||||
| Glucose | cobas c 503 | Human | S/U | Qualified | |||
| GFAP | Simoa | Human | CSF/E/S | 0-20 000 pg/ml | 0,441 | ||
| GFAP | Simoa | Human | CSF/E/S | 0-40 000 pg/ml | 1,18 pg/ml | ||
| GFAP | Simoa | Human | CSF/E/S | 0-4000 pg/ml | 0,221 pg/ml | ||
| GFAP | Simoa | Human | CSF/E/S | 0-40 ng/ml | 0,475 pg/ml | ||
| GFAP | Simoa | Human | CSF/E/S | 0-4 ng/ml | 0,211 pg/ml | ||
| gdf-15 | Cobas e 801 | Human | Qualified | ||||
| GCP-2 / CXCL6 | Bio-Plex® 200 system | Human | E/S | ||||
| Gamma GT | cobas c 503 | Human | Qualified | ||||
| G-CSF | Simoa | Human | E/S | 0 - 3 200 | 0,179 | ||
| G-CSF | Bio-Plex® 200 system | Human | CP/S | ||||
| G-CSF | Simoa | Human | E/S | 0-400 pg/ml | 0,095 pg/ml | ||
| FT3 III | Cobas e 801 | Human | Qualified | ||||
| FSH online | cobas c 503 | Human | Qualified | ||||
| Free T4 | cobas c 503 | Human | Qualified | ||||
| free βhCG | Cobas e 801 | Human | Qualified | ||||
| Free T3 | cobas c 503 | Human | Qualified | ||||
| Free PSA | cobas c 503 | Human | Qualified | ||||
| Free PSA | Cobas e 801 | Human | Qualified | ||||
| Free Protein S | ACL TOP 700 | Human | CP | ISO/IEC 17025 certified | 11 - 150% | 3,5% | |
| Free H3 Histone | TECAN | Human | E | Experienced | 0,30 - 10 ng/mL | ||
| Fractalkine / CX3CL1 | Bio-Plex® 200 system | Human | E/S | ||||
| Folate III | Cobas e 801 | Human | Qualified | ||||
| Foetoprotein Alpha | cobas c 503 | Human | Qualified | ||||
| Fibrinogen | Start Max | Qualified | |||||
| Fibrinogen | STA-R MAX | Qualified | |||||
| Fibrinogen | Simoa | Human | E | 0 - 300 000 ug/ml | 12,5 | ||
| Fibrinogen | ACL TOP 700 | Human | CP/S | Validated | 60 - 700 mg/dL | 2,8% | |
| Fibrin Monomers | STA-R MAX | Qualified | |||||
| Fibrin generation assay | ACL TOP 700 | Human | CP | Qualified | |||
| Fibrin | STA-R MAX | Qualified | |||||
| FGFb | Simoa | Human | 0-2000 | 0,9 | |||
| FGF basic | Simoa | Human | E/S | Not available | |||
| FGF basic | Bio-Plex® 200 system | Human | CP/S | ||||
| FGF basic | Simoa | Human | E/S | 0 - 8 000 | 1,37 | ||
| Ferritin | Cobas e 801 | Human | Qualified | ||||
| FasL | Simoa | Human | E/S | 0 - 3200 | 0,158 | ||
| Factor XIII | STA-R MAX | Qualified | |||||
| Factor XII activity | ACL TOP 700 | Human | CP | Experienced | 1 -150% | ||
| Factor XI activity | ACL TOP 700 | Human | CP | Experienced | 1 -150% | ||
| Factor X activity | ACL TOP 700 | Human | CP | Experienced | 1 -150% | ||
| Factor VIII | ACL TOP 700 | Human | CP | ISO/IEC 17025 certified | 5 - 150% | 6,5% | |
| Factor VII activity | ACL TOP 700 | Human | CP | Experienced | 1 -150% | ||
| Factor V activity | ACL TOP 700 | Human | CP | Experienced | 1 -150% | ||
| Factor IX activity | ACL TOP 700 | Human | CP | Experienced | 1 -150% | ||
| Factor II activity | ACL TOP 700 | Human | CP | Experienced | 1 -150% | ||
| Extrinsic pathway factors | Start Max | Qualified | |||||
| Extrinsic pathway factors | STA-R MAX | Qualified | |||||
| Everolimus | Cobas e 801 | Human | Qualified | ||||
| Epiregulin | Simoa | Human | CP/S | 0 - 10 ng/ml | 82,1 fg/ml | ||
| Eotaxin-3/CCL26 | Bio-Plex® 200 system | Human | E/S | ||||
| Eotaxin-2 / CCL24 | Bio-Plex® 200 system | Human | E/S | ||||
| Eotaxin / CCL11 | Bio-Plex® 200 system | Human | CP/S | ||||
| Eotaxin / CCL11 | Simoa | Human | E/S | 0 - 1 000 | 0,132 | ||
| Digoxin | Cobas e 801 | Human | Qualified | ||||
| Eotaxin / CCL11 | Bio-Plex® 200 system | Human | E/S | ||||
| Endoglin | Simoa | Human | E/S | 0 - 500 ng/ml | 1,47 | ||
| Endogenous thrombin potential (ETP)-based activated protein C resistance assay | Fluoroskan Ascent FL | Human | CP | CE-IVD | 8,2% | ||
| ENA-78/CXCL5 | Bio-Plex® 200 system | Human | E/S | ||||
| Edoxaban-M4 | UHPLC-MS/MS | Experienced | |||||
| EGF | Simoa | Human | E/S | 0 - 400 | 45,8 fg/ml | ||
| Edoxaban | UHPLC-MS/MS | Experienced | |||||
| EBV EBNA IgG | Cobas e 801 | Human | Qualified | ||||
| E-selectin | Simoa | Human | CP/S | Not available | |||
| Digitoxin | Cobas e 801 | Human | Qualified | ||||
| CRP | Simoa | Human | E/S | 0 - 90 ug/ml | 0,348 | ||
| CRP | cobas c 503 | Human | Qualified | ||||
| CTACK / CCL27 | Bio-Plex® 200 system | Human | E/S | ||||
| Cyclosporine | Cobas e 801 | Human | Qualified | ||||
| CYFRA 21-1 | Cobas e 801 | Human | Qualified | ||||
| D-dimers | STA-R MAX | Qualified | |||||
| D-dimers | ACL TOP 700 | Human | CP | Validated | 215 - 128 000 ng/mL | ||
| Dabigatran | UHPLC-MS/MS | Experienced | |||||
| DHEA-S | Cobas e 801 | Human | Qualified | ||||
| CrossLaps | cobas c 503 | Human | Qualified | ||||
| Creatinin | cobas c 503 | Human | S/U | Qualified | |||
| CPK | cobas c 503 | Human | Qualified | ||||
| Cortisol III | Cobas e 801 | Human | Qualified | ||||
| Cortisol II | Cobas e 801 | Human | Qualified | ||||
| Cortisol | cobas c 503 | Human | Qualified | ||||
| Cocaïne metabolites | cobas c 503 | Human | U | Qualified | |||
| CMV IgM | Cobas e 801 | Human | Qualified | ||||
| CMV IgG Avidity | Cobas e 801 | Human | Qualified | ||||
| CK-MB | Cobas e 801 | Human | Qualified | ||||
| Cholesterol HDL | cobas c 503 | Human | Qualified | ||||
| Chloride | cobas c 503 | Human | S/U | Qualified | |||
| Chagas | Cobas e 801 | Human | Qualified | ||||
| CEA | Cobas e 801 | Human | Qualified | ||||
| CEA | Simoa | Human | E/S | Not available | |||
| CEA | Cobas e 801 | Human | Qualified | ||||
| CD-14 | Simoa | Human | E/S | 0 - 16 000 | 0,258 | ||
| Cathepsin S | Simoa | Human | E/S | Not available | |||
| Carbamazepin | cobas c 503 | Human | Qualified | ||||
| Cannabis and metabolites | cobas c 503 | Human | U | Qualified | |||
| Calcium | cobas c 503 | Human | S/U | Qualified | |||
| Calcitonin | cobas c 503 | Human | Qualified | ||||
| Calcitonin | Cobas e 801 | Human | Qualified | ||||
| Calcitonin | Cobas e 801 | Human | Qualified | ||||
| CA 72-4 | Cobas e 801 | Human | Qualified | ||||
| CA 15-3 II | Cobas e 801 | Human | Qualified | ||||
| CA 125 II | Cobas e 801 | Human | Qualified | ||||
| C6kine/CCL21 | Bio-Plex® 200 system | Human | E/S | ||||
| C4 complement | cobas c 503 | Human | Qualified | ||||
| C3 complement | cobas c 503 | Human | Qualified | ||||
| C-Peptide | Cobas e 801 | Human | Qualified | ||||
| C-peptide | Simoa | Human | E/S | 0-400 pg/ml | 0,013 pg/ml | ||
| C-MET | Simoa | Human | E/S | Not available | |||
| BMP-9 | Simoa | Human | E/S | 0 - 5 000 | 0,634 | ||
| Bilirubine | cobas c 503 | Human | Qualified | ||||
| Bicarbonate | cobas c 503 | Human | Qualified | ||||
| Beta HCG | cobas c 503 | Human | Qualified | ||||
| Benzodiazepin | cobas c 503 | Human | U | Qualified | |||
| BDNF | Simoa | Human | CSF/E/S | 0-64 ng/ml | 0,011 pg/ml | ||
| BCA-1 / CXCL13 | Bio-Plex® 200 system | Human | E/S | ||||
| BCA-1 / CXCL13 | Simoa | Human | E/S | 0 - 1 200 | 0,0085 | ||
| Barbituric | cobas c 503 | Human | U | Qualified | |||
| APTT-based activated protein C resistance assay | ACL TOP 700 | Human | CP | ISO/IEC 17025 certified | 3,0% | ||
| APTT | Start Max | Qualified | |||||
| APTT | STA-R MAX | Qualified | |||||
| Apixaban | UHPLC-MS/MS | Experienced | |||||
| Antitrypsin alpha 1 | cobas c 503 | Human | Qualified | ||||
| Antithrombin | STA-R MAX | Qualified | |||||
| Antiplasmin | STA-R MAX | Qualified | |||||
| Anti-Xa | STA-R MAX | Qualified | |||||
| Anti-TSHR | Cobas e 801 | Human | Qualified | ||||
| Anti-TPO | Cobas e 801 | Human | Qualified | ||||
| ANTI-TPO | Cobas e 801 | Human | Qualified | ||||
| Anti-Thyroglobulin | Cobas e 801 | Human | Qualified | ||||
| Anti-thrombin III | ACL TOP 700 | Human | CP | ISO/IEC 17025 certified | 10-150% | 7,8% | |
| Anti-SARS-CoV-2 S | Cobas e 801 | Human | Qualified | ||||
| Anti-SARS-CoV-2 | Cobas e 801 | Human | Qualified | ||||
| Anti-S COVID 19 | Cobas e 801 | Human | Qualified | ||||
| Anti-N COVID 19 | Cobas e 801 | Human | Qualified | ||||
| Anti-Iia | STA-R MAX | Qualified | |||||
| Anti-HEV IgM | Cobas e 801 | Human | Qualified | ||||
| Anti-HEV IgG | Cobas e 801 | Human | Qualified | ||||
| Anti-HCV II | Cobas e 801 | Human | Qualified | ||||
| Anti-HBe | Cobas e 801 | Human | Qualified | ||||
| Anti-HBc II | Cobas e 801 | Human | Qualified | ||||
| Anti-HBc IgM | Cobas e 801 | Human | Qualified | ||||
| Anti-HAV IgM | Cobas e 801 | Human | Qualified | ||||
| Anti-HAV | Cobas e 801 | Human | Qualified | ||||
| Angiotensinogen | TECAN | Human | S | Validated | 3,1 - 200 µg/mL | 12,5% | |
| ANG-2 | Simoa | Human | 0-5600 | 5,5 | |||
| ANG-2 | Simoa | Human | E/S | 0 - 22 400 | 10,5 | ||
| ANG-2 | Simoa | Human | E/S | Not available | |||
| ANG-1 | Simoa | Human | E/S | 0 - 40 000 | 1,99 | ||
| Amylases | cobas c 503 | Human | S/U | Qualified | |||
| Amphetamin | cobas c 503 | Human | U | Qualified | |||
| Ammonia | cobas c 503 | Human | Qualified | ||||
| Amikacin | cobas c 503 | Human | Qualified | ||||
| AMH | Cobas e 801 | Human | Qualified | ||||
| alpha2-mcroglobulin | Simoa | Human | E/S | 0 - 95 | 10,1 | ||
| Alcalin phosphatase | cobas c 503 | Human | Qualified | ||||
| Albumin | cobas c 503 | Human | Qualified | ||||
| AFP | Cobas e 801 | Human | Qualified | ||||
| ADAMTS13 | TECAN | Human | CP | Experienced | 0 - 1,06 UI/ml | ||
| Activated Protein C resistance | STA-R MAX | Qualified | |||||
| Activated partial thromboplastin time | ACL TOP 700 | Human | CP | ISO/IEC 17025 certified | |||
| Ab40 | Simoa | Human | CSF/E | 0-800 pg/ml | 0,20 | ||
| Ab40 | Simoa | Human | CSF/E/S | 0-280 pg/ml | 0,384 | ||
| Ab42 | Simoa | Human | CSF/E | 0-400 pg/ml | 0,045 | ||
| Ab42 | Simoa | Human | CSF/E/S | 0-100 pg/ml | 0,136 | ||
| Activated Clotting Time | Human | Experienced |
*Legend
- B = Whole Blood
- CP = citrated plasma
- CSF = cephalorachidian liquid
- E = EDTA
- S = serum
- U = urine